Stocks
Neurotrope (NTRP) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -5.08 | -7.28 | -8.57 | -7.70 | -11.0 | |||
| Changes by years, y/y, % | -66% | +43% | +18% | -100% | +11.0% | ||||
Neurotrope. EBITDA US GAAP, bln rub
Neurotrope. EBITDA US GAAP, changes, %
Neurotrope. EBITDA US GAAP, sum by quarters, bln rub
Neurotrope (NTRP) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -1.62 | -2.04 | -3.96 | -2.39 | -2.65 | -11.0 | |
| Changes by years, y/y, % | +70% | -51% | +63% | |||||
| Changes by quarters, q/q, % | -61% | +25% | +95% | -40% | +11% | |||
